SWOT Analysis for JFL Life Sciences Ltd.

Relative Outperformance versus Industry over 1 Month
Relative Outperformance versus Industry over 1 Month
Effectively using Shareholders fund - Return on equity (ROE) improving since last 2 year
Growth in Net Profit with increasing Profit Margin (QoQ)
Companies with Low Debt
Company able to generate Net Cash - Improving Net Cash Flow for last 2 years
Annual Net Profits improving for last 2 years
Companies with Zero Promoter Pledge
Rising Delivery Percentage Compared to Previous Day and Month, Strong Volumes
Volume Shockers

Bearish Stocks - Stocks with Medium to Low Trendlyne Momentum Score
Declining Revenue every quarter for the past 3 quarters
Low Piotroski Score : Companies with weak financials
Increasing Trend in Non-Core Income
Highest fall from 52 Week High
Top Losers
Stocks Underperforming their Industry Price Change in the Quarter

Rising Delivery Percentage Compared to Prev Day
Bullish or Bearish Candlestick Strength - Indices
Average Affordability - Stocks with Medium Trendlyne Valuation Score versus Benchmarks

JFL Life Sciences Ltd. SWOT Analysis: Strengths, Weakness, Opportunity, and Threats